Europe Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Europe influenza treatment market accounted for USD 187.6 million in 2019 and will grow by 3.6% annually over 2020-2030 owing to the rising incidences of influenza, growing awareness and need for new drugs and treatment amid COVID-19 pandemic.

Highlighted with 33 tables and 44 figures, this 100-page report Europe Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe influenza treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe influenza treatment market in every aspect of the classification from perspectives of Product Type, Influenza Type, Administration Route, Distribution Channel, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Oseltamivir Phosphate

Baloxavir Marboxil

Peramivir

Zanamivir

Other Drugs

Based on Influenza Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Influenza A

Influenza B

Influenza C

Based on Administration Route, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Oral Administration

Other Administration Routes

Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Retail Pharmacy

Hospital Pharmacy

Clinics

Online Stores

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Administration Route, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe influenza treatment market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

AstraZeneca Plc

BioCryst Pharmaceuticals Inc.

Biondvax

Daiichi Sankyo Company

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)

GlaxoSmithKline Plc

Mylan N.V

Natco Pharma Limited

Novartis AG

Sanofi

Seqirus

Teva Pharmaceutical Industries Limited

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

AstraZeneca Plc

BioCryst Pharmaceuticals Inc.

Biondvax

Daiichi Sankyo Company

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)

GlaxoSmithKline Plc

Mylan N.V

Natco Pharma Limited

Novartis AG

Sanofi

Seqirus

Teva Pharmaceutical Industries Limited

Table of Contents

Table of Contents

1 Introduction 6

1.1 Industry Definition and Research Scope 6

1.1.1 Industry Definition 6

1.1.2 Research Scope 7

1.2 Research Methodology 10

1.2.1 Overview of Market Research Methodology 10

1.2.2 Market Assumption 11

1.2.3 Secondary Data 11

1.2.4 Primary Data 11

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on the Market 20

2.2 Major Growth Drivers 22

2.3 Market Restraints and Challenges 26

2.4 Emerging Opportunities and Market Trends 29

2.5 Porter's Fiver Forces Analysis 33

3 Segmentation of Europe Market by Product Type 37

3.1 Market Overview by Product Type 37

3.2 Oseltamivir Phosphate 39

3.3 Baloxavir Marboxil 40

3.4 Peramivir 41

3.5 Zanamivir 42

3.6 Other Drugs 43

4 Segmentation of Europe Market by Influenza Type 44

4.1 Market Overview by Influenza Type 44

4.2 Influenza A 46

4.3 Influenza B 47

4.4 Influenza C 48

5 Segmentation of Europe Market by Administration Route 49

5.1 Market Overview by Administration Route 49

5.2 Oral Administration 51

5.3 Other Administration Routes 52

6 Segmentation of Europe Market by Distribution Channel 53

6.1 Market Overview by Distribution Channel 53

6.2 Retail Pharmacy 55

6.3 Hospital Pharmacy 56

6.4 Clinics 57

6.5 Online Stores 58

7 European Market 2019-2030 by Country 59

7.1 Overview of European Market 59

7.2 Germany 62

7.3 UK 64

7.4 France 67

7.5 Spain 69

7.6 Italy 71

7.7 Russia 73

7.8 Rest of European Market 75

8 Competitive Landscape 77

8.1 Overview of Key Vendors 77

8.2 New Product Launch, Partnership, Investment, and M&A 80

8.3 Company Profiles 81

AstraZeneca Plc 81

BioCryst Pharmaceuticals Inc. 83

Biondvax 84

Daiichi Sankyo Company 85

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.) 86

GlaxoSmithKline Plc 87

Mylan N.V 88

Natco Pharma Limited 89

Novartis AG 90

Sanofi 91

Seqirus 92

Teva Pharmaceutical Industries Limited 93

9 Investing in Europe Market: Risk Assessment and Management 94

9.1 Risk Evaluation of Europe Market 94

9.2 Critical Success Factors (CSFs) 97

Related Reports and Products 100


List of Figure

Figure 1. Research Method Flow Chart 10

Figure 2. Breakdown of Primary Research 12

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16

Figure 5. Europe Influenza Treatment Market, 2019-2030, USD mn 19

Figure 6. Impact of COVID-19 on Business 20

Figure 7. Primary Drivers and Impact Factors of Europe Influenza Treatment Market 22

Figure 8. GDP per capita in the World, 1960-2018, USD thousand 25

Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 25

Figure 10. Primary Restraints and Impact Factors of Europe Influenza Treatment Market 26

Figure 11. Investment Opportunity Analysis 30

Figure 12. Porter's Fiver Forces Analysis of Europe Influenza Treatment Market 33

Figure 13. Breakdown of Europe Influenza Treatment Market by Product Type, 2019-2030, % of Revenue 37

Figure 14. Europe Addressable Market Cap in 2020-2030 by Product Type, Value (USD mn) and Share (%) 38

Figure 15. Europe Influenza Treatment Market: Oseltamivir Phosphate, 2019-2030, USD mn 39

Figure 16. Europe Influenza Treatment Market: Baloxavir Marboxil, 2019-2030, USD mn 40

Figure 17. Europe Influenza Treatment Market: Peramivir, 2019-2030, USD mn 41

Figure 18. Europe Influenza Treatment Market: Zanamivir, 2019-2030, USD mn 42

Figure 19. Europe Influenza Treatment Market: Other Drugs, 2019-2030, USD mn 43

Figure 20. Breakdown of Europe Influenza Treatment Market by Influenza Type, 2019-2030, % of Sales Revenue 44

Figure 21. Europe Addressable Market Cap in 2020-2030 by Influenza Type, Value (USD mn) and Share (%) 45

Figure 22. Europe Influenza Treatment Market: Influenza A, 2019-2030, USD mn 46

Figure 23. Europe Influenza Treatment Market: Influenza B, 2019-2030, USD mn 47

Figure 24. Europe Influenza Treatment Market: Influenza C, 2019-2030, USD mn 48

Figure 25. Breakdown of Europe Influenza Treatment Market by Administration Route, 2019-2030, % of Sales Revenue 49

Figure 26. Europe Addressable Market Cap in 2020-2030 by Administration Route, Value (USD mn) and Share (%) 50

Figure 27. Europe Influenza Treatment Market: Oral Administration, 2019-2030, USD mn 51

Figure 28. Europe Influenza Treatment Market: Other Administration Routes, 2019-2030, USD mn 52

Figure 29. Breakdown of Europe Influenza Treatment Market by Distribution Channel, 2019-2030, % of Revenue 53

Figure 30. Europe Addressable Market Cap in 2020-2030 by Distribution Channel, Value (USD mn) and Share (%) 54

Figure 31. Europe Influenza Treatment Market: Retail Pharmacy, 2019-2030, USD mn 55

Figure 32. Europe Influenza Treatment Market: Hospital Pharmacy, 2019-2030, USD mn 56

Figure 33. Europe Influenza Treatment Market: Clinics, 2019-2030, USD mn 57

Figure 34. Europe Influenza Treatment Market: Online Stores, 2019-2030, USD mn 58

Figure 35. Breakdown of European Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 60

Figure 36. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 61

Figure 37. Influenza Treatment Market in Germany, 2019-2030, USD mn 62

Figure 38. Influenza Treatment Market in UK, 2019-2030, USD mn 64

Figure 39. Influenza Treatment Market in France, 2019-2030, USD mn 67

Figure 40. Influenza Treatment Market in Spain, 2019-2030, USD mn 69

Figure 41. Influenza Treatment Market in Italy, 2019-2030, USD mn 71

Figure 42. Influenza Treatment Market in Russia, 2019-2030, USD mn 73

Figure 43. Influenza Treatment Market in Rest of Europe, 2019-2030, USD mn 75

Figure 44. Growth Stage of Europe Influenza Treatment Industry over the Forecast Period 77


List of Table

Table 1. Snapshot of Europe Influenza Treatment Market, 2019-2030 17

Table 2. Main Product Trends and Market Opportunities in Europe Influenza Treatment Market 29

Table 3. Europe Influenza Treatment Market by Product Type, 2019-2030, USD mn 37

Table 4. Europe Influenza Treatment Market by Influenza Type, 2019-2030, USD mn 44

Table 5. Europe Influenza Treatment Market by Administration Route, 2019-2030, USD mn 49

Table 6. Europe Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 53

Table 7. Europe Influenza Treatment Market by Country, 2019-2030, USD mn 61

Table 8. Germany Influenza Treatment Market by Product Type, 2019-2030, USD mn 63

Table 9. Germany Influenza Treatment Market by Administration Route, 2019-2030, USD mn 63

Table 10. Germany Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 63

Table 11. UK Influenza Treatment Market by Product Type, 2019-2030, USD mn 66

Table 12. UK Influenza Treatment Market by Administration Route, 2019-2030, USD mn 66

Table 13. UK Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 66

Table 14. France Influenza Treatment Market by Product Type, 2019-2030, USD mn 68

Table 15. France Influenza Treatment Market by Administration Route, 2019-2030, USD mn 68

Table 16. France Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 68

Table 17. Spain Influenza Treatment Market by Product Type, 2019-2030, USD mn 70

Table 18. Spain Influenza Treatment Market by Administration Route, 2019-2030, USD mn 70

Table 19. Spain Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 70

Table 20. Italy Influenza Treatment Market by Product Type, 2019-2030, USD mn 72

Table 21. Italy Influenza Treatment Market by Administration Route, 2019-2030, USD mn 72

Table 22. Italy Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 72

Table 23. Russia Influenza Treatment Market by Product Type, 2019-2030, USD mn 74

Table 24. Russia Influenza Treatment Market by Administration Route, 2019-2030, USD mn 74

Table 25. Russia Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 74

Table 26. Influenza Treatment Market in Rest of Europe by Country, 2019-2030, USD mn 76

Table 27. AstraZeneca Plc: Company Snapshot 81

Table 28. AstraZeneca Plc: Business Segmentation 81

Table 29. AstraZeneca Plc: Product Portfolio 82

Table 30. AstraZeneca Plc: Revenue, 2016-2018, USD mn 82

Table 31. AstraZeneca Plc: Recent Developments 82

Table 32. Risk Evaluation for Investing in Europe Market, 2019-2030 95

Table 33. Critical Success Factors and Key Takeaways 98

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us